Tyloxapol
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.209.660 |
| Chemical and physical data | |
| Formula | (C15H21O(C2H4O)m)n |
| Molar mass | variable |
  (what is this?) (verify) | |
Tyloxapol is a nonionic liquid polymer of the alkyl aryl polyether alcohol type. It is used as a surfactant to aid liquefaction and removal of mucopurulent[citation needed] (containing mucus and pus) bronchopulmonary secretions,[1][2] administered by inhalation through a nebulizer[3] or with a stream of oxygen.
With intraperitoneal injection, tyloxapol also blocks plasma lipolytic activity, and thus the breakdown of triglyceride-rich lipoproteins. This mechanism is used to induce experimental hyperlipidemia in animals.[4]
Tyloxapol is the main active ingredient of the agent Tacholiquin. Tacholiquin is an Expectorant designated for inhaling and instillation into the airways. Other brand names of pharmaceutical products containing Tyloxpol are Exosurf, Alevaire.
References
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 8151722, please use {{cite journal}} with
|pmid=8151722instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 1555424, please use {{cite journal}} with
|pmid=1555424instead. - ^ Drugs.com: Tyloxapol definition
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 12231215, please use {{cite journal}} with
|pmid=12231215instead.
 | This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |